STUDY OF CD4 COUNT IN PRE-ART PERIOD AND DURING ART PERIOD IN SEROPOSITIVE HIV ADULT PATIENTS TO SEE THE EFFECT OF HAART

被引:0
|
作者
Kumar, Brijesh [1 ]
Gautam, Shri Krishna [1 ]
Anita [2 ]
Kumar, Lalit [1 ]
Kumar, Pradeep [1 ]
Khan, Mohd Imran [1 ]
机构
[1] GSVM Med Coll, Dept Med, Kanpur, Uttar Pradesh, India
[2] GSVM Med Coll, Family Planning, Kanpur, Uttar Pradesh, India
关键词
HIV; ART; CD4; Count; ANTIRETROVIRAL THERAPY; CELL COUNT;
D O I
10.14260/jemds/2019/84
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Cases of HIV are increasing all over the world. India is the third largest in terms of HIV epidemic. This disease has put economic burden over the country. Hence we conducted this study to compare CD4 Count before starting ART and during ART period in seropositive HIV adult patients. Aims and Objectives-To study CD4 Count in pre-ART period and during ART period in seropositive HIV adult patients after 2 weeks, 4 months, 8 months, 16 months and 20 months of starting ART. MATERIALS AND METHODS This is a hospital based (observational) cohort study carried out between Dec 2015 to July 2017 among 100 adult HIV positive patients registered at ART-Plus centre, GSVM Medical College, Kanpur. RESULTS Among a total of 100 cases, 70% were males of which majority belonged to younger age group of 20-40 (72%) followed by 40-60 years (17%). HIV infection is more common in married individuals (73%) and in cases belonging to Hindu religion (61%) followed by Muslims (36%). Infection was more common in low socio-economic status. During the period of study, significant rise in CD4 count was noted during the ART period as compared to pre-ART period among study groups of all ages. CONCLUSION The use of ART in adult population of HIV showed a significant rise in CD4 counts both as an immediate (2 wks.) and long-term effect (20 months) as compared to pre-ART period of study and the rise in CD4 counts was progressive over the time period of this study. It was also concluded that there was more significant rise in CD4 count during 2 weeks to 4 months of ART in the younger age group of 18-20 years and 20-40 years. Since HIV is a global disease, with India being the third largest center for HIV epidemic in the word, ART should be started early in the HIV sero-positive patients irrespective of the CD4 count and staging. As it is more prevalent in younger reproductive age groups, these age groups should be better taken care off and educated regarding HIV and methods of its prevention.
引用
收藏
页码:381 / 384
页数:4
相关论文
共 50 条
  • [1] STUDY OF CD4 COUNT IN HIV PATIENTS ON HAART THERAPY
    Vemula, Sreenivasulu
    Rao, Venkateswara K. S. S.
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (95): : 7034 - 7041
  • [2] Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti
    Koenig, Serena P.
    Bernard, Daphne
    Devieux, Jessy G.
    Atwood, Sidney
    McNairy, Margaret L.
    Severe, Patrice
    Marcelin, Adias
    Julma, Pierrot
    Apollon, Alexandra
    Pape, Jean W.
    [J]. PLOS ONE, 2016, 11 (02):
  • [3] Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART
    Pantazis, Nikos
    Paparizos, Vasilios
    Papastamopoulos, Vasilios
    Metallidis, Simeon
    Antoniadou, Anastasia
    Adamis, Georgios
    Psichgiou, Mina
    Chini, Maria
    Sambatakou, Helen
    Chrysos, Georgios V.
    Sipsas, Nikolaos
    Gogos, Charalambos
    Barbunakis, Emmanouil
    Panagopoulos, Periklis
    Katsarou, Olga
    Touloumi, Giota
    [J]. PLOS ONE, 2023, 18 (03):
  • [4] Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART
    Pantazis, N.
    Paparizos, V.
    Papastamopoulos, V.
    Metallidis, S.
    Antoniadou, A.
    Adamis, G.
    Psichogiou, M.
    Chini, M.
    Sambatakou, H.
    Chrysos, G.
    Sipsas, N. V.
    Gogos, C.
    Barbunakis, E.
    Panagopoulos, P.
    Katsarou, O.
    Touloumi, G.
    [J]. HIV MEDICINE, 2019, 20 : 203 - 203
  • [5] CARDIOVASCULAR ABNORMALITIES IN HIV PATIENTS AND THEIR ASSOCIATION WITH DURATION OF HAART AND CD4 COUNT
    Sharma, A.
    Dandu, H.
    Tripathi, A. K.
    Chandra, S.
    [J]. CARDIOLOGY, 2017, 137 : 136 - 136
  • [6] Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda
    Geng, Elvin H.
    Bwana, Mwebesa B.
    Muyindike, Winnie
    Glidden, David V.
    Bangsberg, David R.
    Neilands, Torsten B.
    Bernheimer, Ingrid
    Musinguzi, Nicolas
    Yiannoutsos, Constantin T.
    Martin, Jeffrey N.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (02) : E64 - E71
  • [7] Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3
    Currier, Judith S.
    Britto, Paula
    Hoffman, Risa M.
    Brummel, Sean
    Masheto, Gaerolwe
    Joao, Esau
    Santos, Breno
    Aurpibul, Linda
    Losso, Marcelo
    Pierre, Marie F.
    Weinberg, Adriana
    Gnanashanmugam, Devasena
    Chakhtoura, Nahida
    Klingman, Karin
    Browning, Renee
    Coletti, Anne
    Mofenson, Lynne
    Shapiro, David
    Pilotto, Jose
    [J]. PLOS ONE, 2017, 12 (05):
  • [8] Determinants of CD4 count and risk for death of HIV infected children under ART
    Gwadu, Ayitenew Agegn
    Tegegne, Awoke Seyoum
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] Determinants of CD4 count and risk for death of HIV infected children under ART
    Ayitenew Agegn Gwadu
    Awoke Seyoum Tegegne
    [J]. Scientific Reports, 12
  • [10] Providing Immediate CD4 Count Results at HIV Testing Improves ART Initiation
    Faal, Mamsallah
    Naidoo, Nicolette
    Glencross, Deborah K.
    Venter, Willem D. F.
    Osih, Regina
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (03) : E54 - E59